The Potential Role of Corticosteroid Prophylaxis for the Prevention of Microscopic Fat Embolism Syndrome in Gluteal Augmentations.
Microscopic fat embolism syndrome (micro-FES) has been recently identified as a potentially fatal complication following gluteal augmentation using autologous fat grafts; safety recommendations advocating for subcutaneous lipo-injections may be insufficient for its prevention. This systematic review evaluates the potential role of corticosteroid prophylaxis for the prevention of micro-FES in gluteal augmentation procedures. A systematic search was performed using the National Library of Medicine (PubMed), Medline and Embase databases. Search terms were those pertaining to studies reporting on the efficacy of prophylactic corticosteroid administration on micro-FES incidence in a high-risk surrogate population. Thirteen articles met the inclusion criteria for review, comprising two studies reporting on the efficacy of a single intravenous (IV) corticosteroid dose for the prophylaxis of micro-FES, nine studies reporting on multiple prophylactic IV doses, and two additional studies reporting on the efficacy of inhaled corticosteroids in this context. All studies were identified from the orthopedic literature given that none were available directly from within plastic surgery. The prophylactic efficacy of multiple IV doses of methylprednisolone, or a single larger dose, was established, while the efficacy of inhaled corticosteroids remains elusive. A single perioperative IV dose of methylprednisolone may be most appropriate for use by plastic surgeons; the safety and implication of this therapy on wound healing and fat graft survival are discussed. Further studies directly evaluating the efficacy of corticosteroid prophylaxis in the gluteal augmentation population are indicated. Finally, recommendations pertaining to the prevention, timely recognition, and effective management of micro-FES are discussed.